An Agenda for Addressing Multimorbidity and Racial and Ethnic Disparities in Alzheimer’s Disease and Related Dementia

Ana R. Quiñones; Jeffrey Kaye; Heather G. Allore; Anda Botoseneanu; Stephen M. Thielke

doi:10.1177/1533317520960874

An Agenda for Addressing Multimorbidity and Racial and Ethnic Disparities in Alzheimer’s Disease and Related Dementia

Ana R. Quiñones, Jeffrey Kaye, Heather G. Allore, Anda Botoseneanu, Stephen M. Thielke

Research output: Contribution to journal › Article › peer-review

Abstract

Advancements in Alzheimer’s disease and related dementias (ADRD) research on the U.S. population acknowledge the importance of the high burden of ADRD on segments of the population and yet-to-be characterized risks attributable to the burden of multiple chronic diseases (multimorbidity). These realizations suggest successful strategies in caring for people with ADRD and their caregivers will rely not only on clinical treatments but also on more refined and comprehensive models of ADRD that take its broad effects on the whole-person and the whole of society into consideration. To this end, it is critical to characterize and address the relationship between ADRD and multimorbidity combinations that complicate care and lead to poor outcomes, particularly with regard to racial and ethnic disparities in the occurrence, course, and effects of ADRD. Several research and policy recommendations are presented to address the intersection of ADRD, multimorbidity, and underrepresented populations most at risk for adverse outcomes.

Original language	English (US)
Journal	American Journal of Alzheimer's Disease and Other Dementias
Volume	35
DOIs	https://doi.org/10.1177/1533317520960874
State	Published - 2020

Keywords

Alzheimer’s disease and related dementias
conditions
dementia
health disparities
multimorbidity
multiple chronic
race/ethnicity

ASJC Scopus subject areas

Neuroscience(all)
Clinical Psychology
Geriatrics and Gerontology
Psychiatry and Mental health

Access to Document

10.1177/1533317520960874

Fingerprint Dive into the research topics of 'An Agenda for Addressing Multimorbidity and Racial and Ethnic Disparities in Alzheimer’s Disease and Related Dementia'. Together they form a unique fingerprint.

Cite this

@article{9f919838534e4503873aa8d47572c45e,

title = "An Agenda for Addressing Multimorbidity and Racial and Ethnic Disparities in Alzheimer{\textquoteright}s Disease and Related Dementia",

abstract = "Advancements in Alzheimer{\textquoteright}s disease and related dementias (ADRD) research on the U.S. population acknowledge the importance of the high burden of ADRD on segments of the population and yet-to-be characterized risks attributable to the burden of multiple chronic diseases (multimorbidity). These realizations suggest successful strategies in caring for people with ADRD and their caregivers will rely not only on clinical treatments but also on more refined and comprehensive models of ADRD that take its broad effects on the whole-person and the whole of society into consideration. To this end, it is critical to characterize and address the relationship between ADRD and multimorbidity combinations that complicate care and lead to poor outcomes, particularly with regard to racial and ethnic disparities in the occurrence, course, and effects of ADRD. Several research and policy recommendations are presented to address the intersection of ADRD, multimorbidity, and underrepresented populations most at risk for adverse outcomes.",

keywords = "Alzheimer{\textquoteright}s disease and related dementias, conditions, dementia, health disparities, multimorbidity, multiple chronic, race/ethnicity",

author = "Qui{\~n}ones, {Ana R.} and Jeffrey Kaye and Allore, {Heather G.} and Anda Botoseneanu and Thielke, {Stephen M.}",

note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health (RF1AG058545 to ARQ and R01AG047891 to HGA who contributed from the Yale Claude D. Pepper Older Americans Independence Center P30AG021342; P30AG008017, P30AG066518 and P30AG024978 to JK). ARQ and HGA were supported by the National Institute on Aging (NIA) of the National Institutes of Health under Award Number U54AG063546, which funds the NIA Imbedded Pragmatic Alzheimer{\textquoteright}s Disease and AD-Related Dementias Clinical Trials Collaboratory (NIA IMPACT Collaboratory). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. ",

year = "2020",

doi = "10.1177/1533317520960874",

language = "English (US)",

volume = "35",

journal = "American Journal of Alzheimer's Disease and other Dementias",

issn = "1533-3175",

publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - An Agenda for Addressing Multimorbidity and Racial and Ethnic Disparities in Alzheimer’s Disease and Related Dementia

AU - Quiñones, Ana R.

AU - Kaye, Jeffrey

AU - Allore, Heather G.

AU - Botoseneanu, Anda

AU - Thielke, Stephen M.

N1 - Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health (RF1AG058545 to ARQ and R01AG047891 to HGA who contributed from the Yale Claude D. Pepper Older Americans Independence Center P30AG021342; P30AG008017, P30AG066518 and P30AG024978 to JK). ARQ and HGA were supported by the National Institute on Aging (NIA) of the National Institutes of Health under Award Number U54AG063546, which funds the NIA Imbedded Pragmatic Alzheimer’s Disease and AD-Related Dementias Clinical Trials Collaboratory (NIA IMPACT Collaboratory). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

PY - 2020

Y1 - 2020

N2 - Advancements in Alzheimer’s disease and related dementias (ADRD) research on the U.S. population acknowledge the importance of the high burden of ADRD on segments of the population and yet-to-be characterized risks attributable to the burden of multiple chronic diseases (multimorbidity). These realizations suggest successful strategies in caring for people with ADRD and their caregivers will rely not only on clinical treatments but also on more refined and comprehensive models of ADRD that take its broad effects on the whole-person and the whole of society into consideration. To this end, it is critical to characterize and address the relationship between ADRD and multimorbidity combinations that complicate care and lead to poor outcomes, particularly with regard to racial and ethnic disparities in the occurrence, course, and effects of ADRD. Several research and policy recommendations are presented to address the intersection of ADRD, multimorbidity, and underrepresented populations most at risk for adverse outcomes.

AB - Advancements in Alzheimer’s disease and related dementias (ADRD) research on the U.S. population acknowledge the importance of the high burden of ADRD on segments of the population and yet-to-be characterized risks attributable to the burden of multiple chronic diseases (multimorbidity). These realizations suggest successful strategies in caring for people with ADRD and their caregivers will rely not only on clinical treatments but also on more refined and comprehensive models of ADRD that take its broad effects on the whole-person and the whole of society into consideration. To this end, it is critical to characterize and address the relationship between ADRD and multimorbidity combinations that complicate care and lead to poor outcomes, particularly with regard to racial and ethnic disparities in the occurrence, course, and effects of ADRD. Several research and policy recommendations are presented to address the intersection of ADRD, multimorbidity, and underrepresented populations most at risk for adverse outcomes.

KW - Alzheimer’s disease and related dementias

KW - conditions

KW - dementia

KW - health disparities

KW - multimorbidity

KW - multiple chronic

KW - race/ethnicity

UR - http://www.scopus.com/inward/record.url?scp=85091540389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091540389&partnerID=8YFLogxK

U2 - 10.1177/1533317520960874

DO - 10.1177/1533317520960874

M3 - Article

C2 - 32969234

AN - SCOPUS:85091540389

VL - 35

JO - American Journal of Alzheimer's Disease and other Dementias

JF - American Journal of Alzheimer's Disease and other Dementias

SN - 1533-3175

ER -